Christopher Mengel

OTCMKTS:WNDW – Get Free Report ) released its quarterly earnings results on Tuesday. The company reported ($0.01) earnings per share for the quarter, Zacks reports.

CV Sciences Stock Down 12.8 % OTCMKTS CVSI traded down $0.00 on Tuesday, hitting $0.03.

(NYSE: SEE) recently received a number of ratings updates from brokerages and research firms:

Other institutional investors and hedge funds have also modified their holdings of the company.

Unum Group ( NYSE:UNM – Free Report had its price objective upped by Wells Fargo & Company from $74.00 to $81.00 in a research report sent to investors on Tuesday, Benzinga reports.

A number of other institutional investors have also recently bought and sold shares of the business.

Medexus Pharmaceuticals ( TSE:MDP – Free Report had its price target hoisted by Stifel Nicolaus from C$4.15 to C$4.50 in a research note published on Tuesday, BayStreet.CA reports.

Other hedge funds have also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. boosted its holdings in shares of Global X Uranium ETF by 50.9% during the third quarter.

A number of other large investors also recently bought and sold shares of TGT. Prime Capital Investment Advisors LLC raised its holdings in Target by 16.2% during the second quarter.

A number of other large investors have also recently bought and sold shares of VOX. GSA Capital Partners LLP acquired a new position in Vanguard